149 related articles for article (PubMed ID: 9642485)
1. Treatment of angina pectoris with calcium antagonists: long-term follow-up.
Behar S
Cardiovasc Drugs Ther; 1998 Apr; 12 Suppl 1():119-24. PubMed ID: 9642485
[TBL] [Abstract][Full Text] [Related]
2. Prognostic effects of calcium channel blockers on cardiac events, stroke and end-stage renal disease in patients with angina pectoris. Retrospective comparative study of benidipine, diltiazem and nifedipine.
Arioka I; Dohi S; Dohi S; Sakai K
Arzneimittelforschung; 2008; 58(9):435-40. PubMed ID: 18972872
[TBL] [Abstract][Full Text] [Related]
3. Calcium channel blocking agents and risk of cancer in patients with coronary heart disease. Benzafibrate Infarction Prevention (BIP) Study Research Group.
Braun S; Boyko V; Behar S; Reicher-Reiss H; Laniado S; Kaplinsky E; Goldbourt U
J Am Coll Cardiol; 1998 Mar; 31(4):804-8. PubMed ID: 9525550
[TBL] [Abstract][Full Text] [Related]
4. B-vitamin Treatment Modifies the Mortality Risk Associated with Calcium Channel Blockers in Patients with Suspected Stable Angina Pectoris: A Prospective Cohort Study.
Dhar I; Svingen GF; Bjørnestad EØ; Ulvik A; Saeed S; Nygård OK
Am J Clin Nutr; 2023 Jul; 118(1):77-84. PubMed ID: 37121550
[TBL] [Abstract][Full Text] [Related]
5. Lesion severity and hypercholesterolemia determine long-term prognosis of vasospastic angina treated with calcium channel antagonists.
Yamagishi M; Ito K; Tsutsui H; Miyazaki S; Goto Y; Nagaya N; Sumiyoshi T; Fukami K; Haze K; Kitakaze M; Nonogi H; Tomoike H
Circ J; 2003 Dec; 67(12):1029-35. PubMed ID: 14639019
[TBL] [Abstract][Full Text] [Related]
6. Long-acting calcium antagonists in patients with coronary artery disease: a meta-analysis.
Bangalore S; Parkar S; Messerli FH
Am J Med; 2009 Apr; 122(4):356-65. PubMed ID: 19332231
[TBL] [Abstract][Full Text] [Related]
7. Concomitant administration of clopidogrel with statins or calcium-channel blockers: insights from the TRITON-TIMI 38 (trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-thrombolysis in myocardial infarction 38).
Ojeifo O; Wiviott SD; Antman EM; Murphy SA; Udell JA; Bates ER; Mega JL; Sabatine MS; O'Donoghue ML
JACC Cardiovasc Interv; 2013 Dec; 6(12):1275-81. PubMed ID: 24239201
[TBL] [Abstract][Full Text] [Related]
8. Comparison of calcium-channel blockers for long-term clinical outcomes in patients with vasospastic angina.
Kim SE; Jo SH; Han SH; Lee KY; Her SH; Lee MH; Seo WW; Cho SS; Baek SH
Korean J Intern Med; 2021 Jan; 36(1):124-134. PubMed ID: 32088938
[TBL] [Abstract][Full Text] [Related]
9. Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment (ACTION trial): randomised controlled trial.
Poole-Wilson PA; Lubsen J; Kirwan BA; van Dalen FJ; Wagener G; Danchin N; Just H; Fox KA; Pocock SJ; Clayton TC; Motro M; Parker JD; Bourassa MG; Dart AM; Hildebrandt P; Hjalmarson A; Kragten JA; Molhoek GP; Otterstad JE; Seabra-Gomes R; Soler-Soler J; Weber S;
Lancet; 2004 Sep 4-10; 364(9437):849-57. PubMed ID: 15351192
[TBL] [Abstract][Full Text] [Related]
10. Prior calcium channel blockade and short-term survival following acute myocardial infarction.
Parsons RW; Hung J; Hanemaaijer I; Jbroadhurst R; Jamrozik K; Hobbs MS
Cardiovasc Drugs Ther; 2001 Nov; 15(6):487-92. PubMed ID: 11916357
[TBL] [Abstract][Full Text] [Related]
11. Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with symptomatic stable angina and hypertension: the ACTION trial.
Lubsen J; Wagener G; Kirwan BA; de Brouwer S; Poole-Wilson PA;
J Hypertens; 2005 Mar; 23(3):641-8. PubMed ID: 15716708
[TBL] [Abstract][Full Text] [Related]
12. The role of calcium antagonists in the treatment of myocardial ischemia.
Follath F
Am Heart J; 1989 Nov; 118(5 Pt 2):1093-6; discussion 1096-7. PubMed ID: 2683702
[TBL] [Abstract][Full Text] [Related]
13. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial.
Chaitman BR; Pepine CJ; Parker JO; Skopal J; Chumakova G; Kuch J; Wang W; Skettino SL; Wolff AA;
JAMA; 2004 Jan; 291(3):309-16. PubMed ID: 14734593
[TBL] [Abstract][Full Text] [Related]
14. Calcium channel blockers and cardiac mortality in the treatment of hypertension: a report from the Department of Health Hypertension Care Computing Project (DHCCP).
Bulpitt CJ; Palmer AJ; Beevers DG; Coles EC; Ledingham JG; Petrie JC; Webster J
J Hum Hypertens; 1997 Apr; 11(4):205-11. PubMed ID: 9185024
[TBL] [Abstract][Full Text] [Related]
15. Proposed synergistic effect of calcium channel blockers with lipid-lowering therapy in retarding progression of coronary atherosclerosis.
Jukema JW; van Boven AJ; Zwinderman AH; Van der Laarse A; Bruschke AV
Cardiovasc Drugs Ther; 1998 Apr; 12 Suppl 1():111-8. PubMed ID: 9642484
[TBL] [Abstract][Full Text] [Related]
16. Long-term survival after myocardial infarction: relationship with thrombolysis and discharge medication. Results of the Augsburg Myocardial Infarction Follow-up Study 1985 to 1993.
Koenig W; Löwel H; Lewis M; Hörmann A
Eur Heart J; 1996 Aug; 17(8):1199-206. PubMed ID: 8869861
[TBL] [Abstract][Full Text] [Related]
17. Favourable long term prognosis in stable angina pectoris: an extended follow up of the angina prognosis study in Stockholm (APSIS).
Hjemdahl P; Eriksson SV; Held C; Forslund L; Näsman P; Rehnqvist N
Heart; 2006 Feb; 92(2):177-82. PubMed ID: 15951393
[TBL] [Abstract][Full Text] [Related]
18. Choosing the most appropriate treatment for stable angina. Safety considerations.
Asirvatham S; Sebastian C; Thadani U
Drug Saf; 1998 Jul; 19(1):23-44. PubMed ID: 9673856
[TBL] [Abstract][Full Text] [Related]
19. Calcium channel blockers and clinical outcomes in patients with continuous-flow left ventricular assist devices.
Tie H; Li Z; Welp H; Guha A; Caraballo C; Deschka H; Shi R; Zheng X; Martens S; Sindermann J; Chen D; Wu Q; Martens S
ESC Heart Fail; 2024 Feb; 11(1):271-281. PubMed ID: 37967837
[TBL] [Abstract][Full Text] [Related]
20. Safety of long-acting dihydropyridine calcium channel blockers in hypertensive patients.
Kloner RA; Vetrovec GW; Materson BJ; Levenstein M
Am J Cardiol; 1998 Jan; 81(2):163-9. PubMed ID: 9591899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
